Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 27.07.2021 at 12:00 PM CEST
Settings

Settings

Goto Application

1. WO2020135872 - IMMUNOSUPPRESSIVE PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

Publication Number WO/2020/135872
Publication Date 02.07.2020
International Application No. PCT/CN2019/129945
International Filing Date 30.12.2019
IPC
A61K 31/35 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
A61K 31/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
A61K 31/54 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
54having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame
A61P 17/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
A61K 31/352 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
C07D 405/12 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
405Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
CPC
A61K 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
A61K 31/35
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 31/54
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
54having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
A61P 17/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
C07D 311/92
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
311Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
02ortho- or peri-condensed with carbocyclic rings or ring systems
78Ring systems having three or more relevant rings
92Naphthopyrans; Hydrogenated naphthopyrans
Applicants
  • 上海明隽生物技术有限公司 SHANGHAI ARCHEUS BIOTECH CO., LTD. [CN]/[CN]
Inventors
  • 巩晓明 GONG, Xiaoming
Agents
  • 北京华睿卓成知识产权代理事务所(普通合伙) CHENG & PENG INTELLECTUAL PROPERTY LAW OFFICE
Priority Data
201811645299.029.12.2018CN
Publication Language Chinese (ZH)
Filing Language Chinese (ZH)
Designated States
Title
(EN) IMMUNOSUPPRESSIVE PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
(FR) COMPOSITION PHARMACEUTIQUE IMMUNOSUPPRESSIVE ET SON APPLICATION
(ZH) 免疫抑制药物组合物及其应用
Abstract
(EN)
Provided are a drug, a pharmaceutical composition, or a pharmaceutical kit for immunosuppression, for the treatment of conditions such as psoriasis, comprising a forskolin derivative or a salt thereof and optionally a prostaglandin compound or a glucocorticoid compound. Further provided is a method for immunosuppression, comprising administration of a forskolin derivative or a salt thereof and optionally a prostaglandin compound or a glucocorticoid compound. Forskolin derivatives show promise as a class of small-molecule drugs for achieving immunosuppression using new mechanisms, for the treatment of conditions such as psoriasis, when used alone or in combination with other substances. Compared with first-line antibody drugs, forskolin derivatives have significant advantages in process and price, and have comparable efficacy and fewer side effects compared with the first-line drug calcipotriol betamethasone ointment.
(FR)
L'invention concerne un médicament, une composition pharmaceutique ou un kit pharmaceutique pour l'immunosuppression, destinés au traitement d'états tels que le psoriasis, comprenant un dérivé de forskoline ou un sel de celui-ci et éventuellement un composé de prostaglandine ou un composé glucocorticoïde. L'invention concerne en outre un procédé d'immunosuppression, consistant à administrer un dérivé de forskoline ou d'un sel de celui-ci et éventuellement un composé de prostaglandine ou un composé glucocorticoïde. Les dérivés de forskoline s'avèrent prometteurs en tant que classe de médicaments à petites molécules pour obtenir une immunosuppression à l'aide de nouveaux mécanismes, dans le traitement d'états tels que le psoriasis, lorsqu'ils sont utilisés seuls ou en combinaison avec d'autres substances. Par comparaison avec des médicaments de première ligne à base d'anticorps, des dérivés de forskoline présentent des avantages significatifs en termes de processus et de prix, et ont une efficacité comparable et moins d'effets secondaires par comparaison avec le médicament de première ligne tel qu'un onguent à base de calcipotriol et bétaméthasone.
(ZH)
提供了用于进行免疫抑制如治疗银屑病等的包括福司可林衍生物或其盐以及任选地前列腺素类化合物或糖皮质激素类化合物的药物、药物组合物、或药物试剂盒。还提供了进行免疫抑制的方法,其包括以福司可林衍生物或其盐以及任选地前列腺素类化合物或糖皮质激素类化合物给药。福司可林衍生物在单独或联合用药时有望成为用于免疫抑制如治疗银屑病的一类新机制小分子药物,相较一线抗体用药有显著工艺和价格优势,与临床一线化药卡泊三醇倍他米松软膏相比疗效相当、副作用更少。
Latest bibliographic data on file with the International Bureau